Latest News
Samsung Bioepis begins direct commercialisation of BYOOVIZ in Europe
2 January 2026 - South Korean biopharmaceutical company Samsung Bioepis Co Ltd said on Friday that it has begun direct commercialisation of BYOOVIZ, a biosimilar to Lucentis (ranibizumab), across multiple European countries.The company has completed ...
MemorialCare hospitals recognised in 2026 Women's Choice Awards
2 January 2026 - MemorialCare, a California-based-based not-for-profit, integrated healthcare system, announced on Thursday that its Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center have received multiple honours ...
International Isotopes Inc to change name to Radnostix Inc
2 January 2026 - International Isotopes Inc (INIS) (OTCQB:INIS), a US supplier of generic sodium iodide I-131 radio-pharmaceutical drug products for hyperthyroidism and thyroid cancer, announced on Wednesday that it has filed a Certificate of Amendme...
Elanco Animal Health's Befrena (tirnovetmab) receives USDA approval for canine dermatitis
2 January 2026 - Animal health specialist Elanco Animal Health Incorporated (NYSE:ELAN) announced on Wednesday that it has received approval from the US Department of Agriculture (USDA) for Befrena (tirnovetmab), a new anti-IL31 monoclonal antibody (...
ChemPartner updates its visual identity and digital experience
2 January 2026 - ChemPartner, a China-based global contract research organisation (CRO) serving the biopharmaceutical industry, announced on Thursday the introduction of an updated visual identity and improved digital experience.According to ChemPart...